Purple pills sit in a container. (Photographer: Daniel Acker/Bloomberg)

Morgan Stanley Says Indian Drugmakers Need To Get Into Speciality, Biosimilars Segments

Jun 13 2019, 2:58 AMJun 13 2019, 4:45 AMJune 13 2019, 2:58 AMJune 13 2019, 4:45 AM

Indian pharmaceutical companies’ future growth is dependent on how soon they venture into the specialty drugs and biosimilars business, according to Morgan Stanley Analyst Sameer Baisiwala.“Special...

Morgan Stanley Says Indian Drugmakers Need To Get Into Speciality\, Biosimilars Segments

Morgan Stanley Says Indian Drugmakers Need To Get Into Speciality, Biosimilars Segments